StoxGud Sign in

Poly Medicure vs Vijaya Diagnostic Centre: share price & financials comparison

NSE: POLYMED vs VIJAYA · Healthcare · as of 06 Nov 2026

Poly MedicureNSE: POLYMED₹1,612.30 +0.63%Neutral setup · 6/10vsVijaya Diagnostic CentreNSE: VIJAYA₹1,468.60 +2.15%Bullish setup · 9/10

Both prices rebased to 100 at the start of the selected period.

Poly Medicure vs Vijaya Diagnostic Centre at a glance

Poly Medicure (POLYMED) has a market capitalisation of ₹16,342 Cr, against ₹15,126 Cr for Vijaya Diagnostic Centre (VIJAYA). Over the past year Vijaya Diagnostic Centre has returned +45.8%, compared with -18.1% for Poly Medicure. On valuation, Poly Medicure trades at a lower P/E of 51.3 versus 74.3. Vijaya Diagnostic Centre earns a higher return on equity (19.3% vs 9.8%). Poly Medicure comes out ahead on size, valuation and growth. Vijaya Diagnostic Centre comes out ahead on profitability, momentum and technicals. Across the scored metrics below, Poly Medicure leads on 6 and Vijaya Diagnostic Centre on 10. On StoxGud's 10-point checklist, Poly Medicure scores 6/10 and Vijaya Diagnostic Centre scores 9/10.

MetricPoly MedicureVijaya Diagnostic Centre
Size
Market cap₹16,342 Cr₹15,126 Cr
Revenue (latest FY)₹1,875 Cr₹814 Cr
Net profit (latest FY)₹322 Cr₹173 Cr
Valuation
P/E51.374.3
P/B5.0014.31
Dividend yield0.22%0.14%
Profitability
Return on equity9.8%19.3%
Net profit margin14.9%22.4%
Operating margin22.7%43.1%
Growth
Revenue growth (YoY)+30.8%+26.7%
Net profit growth (YoY)+3.6%+37.4%
Revenue CAGR (multi-year)+19.0%+15.2%
Financial health
Debt to equity0.120.00
Momentum
1-month return-0.2%+0.4%
1-year return-18.1%+45.8%
3-year CAGR+5.5%+35.9%
5-year CAGR+12.2%+21.1%
10-year CAGR+23.6%—
Distance from 52W high-21.9%-6.5%
Technicals
RSI (14)5267
Price vs 200-day avg+4.3%+18.0%

Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.

10-point checklist side by side

CheckPoly MedicureVijaya Diagnostic Centre
Price above 50-day average✗✓
Price above 200-day average✓✓
50-day average above 200-day (uptrend)✓✓
RSI in healthy 40–70 zone✓✓
Positive 1-year return✗✓
Return on equity above 15%✗✓
Debt to equity below 1✓✓
Revenue growing year on year✓✓
Net profit margin above 10%✓✓
P/E below industry median✗✗
Score6/109/10

A rules-based screen for education only — not a buy or sell recommendation.

FAQs

Which is bigger, Poly Medicure or Vijaya Diagnostic Centre?

Poly Medicure has a market cap of ₹16,342 Cr and Vijaya Diagnostic Centre has a market cap of ₹15,126 Cr as of 06 Nov 2026.

Which has a lower P/E, Poly Medicure or Vijaya Diagnostic Centre?

Poly Medicure has the lower P/E: Poly Medicure trades at 51.3 and Vijaya Diagnostic Centre at 74.3.

Which gave better returns in the last year, Poly Medicure or Vijaya Diagnostic Centre?

Vijaya Diagnostic Centre did better: Poly Medicure returned -18.1% and Vijaya Diagnostic Centre returned +45.8% over one year.

Is Poly Medicure or Vijaya Diagnostic Centre a better buy?

StoxGud does not give buy or sell recommendations. On our rules-based checklist Poly Medicure scores 6/10 and Vijaya Diagnostic Centre scores 9/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.

More comparisons